Delivery Order SPE2DB20D3103-SPE2DB24FN0S7
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $2.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $4,879.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,723,201 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of November 7, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award, valued at $9,782.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,416,379 units of Ondansetron HCL 4 mg Tablets in 30-count packages. This is a delivery order contract with a firm fixed-price pricing type, with a completion date of April 29, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award, valued at $10,624.15, was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is a delivery order for the supply of 4,559,022,633 units of 4 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price pricing type and an ultimate completion date of November 8, 2022. It is not designated as a set-aside contract....
- This federal contract award, valued at $4,615.81, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,586,918 units of Ondansetron HCL 8 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,774,936 units of Ondansetron HCL 4 mg tablets. The award, valued at $2,928.70, is a delivery order with a firm fixed price. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,281.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,310,481 units of Ondansetron HCL 4 MG Tablet 30S, a pharmaceutical product used to treat nausea and vomiting. The contract has a period of performance through January 12, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $19,368.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,416 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a firm fixed-price Delivery Order with a completion date of January 24, 2024. It is not designated as a set-aside contract....
- This federal contract award, valued at $12,700.33, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,894,209 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a firm fixed-price delivery order with a completion date of May 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
- This federal contract award, valued at $15,333.05, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of 4,563,445,246 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 26, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award....
- This federal contract award, valued at $1,659.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,731,832 units of the pharmaceutical drug Ondansetron ODT 4 MG Tablet, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of August 8, 2023 and is a firm fixed-price delivery order. It is not associated with any set-aside requirements, indicating full...